We were a collaborator on a recent Innovate UK-funded SBRI project with Binx and the Applied Diagnostic Research and Evaluation Unit at St George’s University of London. In this project, our team compared the overall costs, patient benefits and cost-effectiveness of three different multi-pathogen point-of-care testing strategies with the current strategy of microscopy and lab-based testing.
Personalised medicine is an emerging field that brings exciting changes to patient care. So, what exactly is personalised medicine and what are its benefits?
In the past, various terms have been used interchangeably: ‘stratified medicine’, ‘personalised medicine’ and ‘precision medicine’. These terms refer to data driven medicine, in which data can be a patient’s genetic makeup, molecular data or disposition to respond to therapy. These data allow for a targeted approach to prevention, diagnosis and treatment using technologies such as genomic medicine, diagnostic tests, predictive data analytics or real-time patient monitoring.
Optimising cancer pathways
Pathways for the diagnosis, treatment and follow-up of patients with cancer are complex. Cancer care information is held in different sites, making a holistic view to care challenging. We visualise the different routes to diagnosis and treatment, and quantify the burden to the healthcare system. This provides a more complete understanding of the opportunities for introducing innovation and improvement into cancer care resulting in better outcomes for patients and more efficient services.